Concepedia

Davide Bonanni

DB

Statistics

Publications

9

Citations

378

H-Index

9

Active since

2017

Affiliations

University of Turin(Current)

University of Modena and Reggio Emilia

Mario Negri Institute for Pharmacological Research

University of Gothenburg

A. O. Ordine Mauriziano di Torino

Davide Bonanni is an author at University of Turin specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2017–2023

9

Publications

9

Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5-<i>a</i>]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors

Stefano Sainas, Agnese Chiara Pippione, Elisa Lupino et al. · Journal of Medicinal Chemistry · 2018 · 75 citations · Full text

, , +15

Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents

Laurent R. Chiarelli, Matteo Mori, Daniela Barlocco et al. · European Journal of Medicinal Chemistry · 2018 · 72 citations · Full text

, , +8

Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid

Agnese Chiara Pippione, Irene Maria Carnovale, Davide Bonanni et al. · European Journal of Medicinal Chemistry · 2018 · 50 citations · Full text

, , +16

Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3

Marco L. Lolli, Irene Maria Carnovale, Agnese Chiara Pippione et al. · ACS Medicinal Chemistry Letters · 2019 · 50 citations · Full text

, , +14

Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach

Agnese Chiara Pippione, Alessandro Giraudo, Davide Bonanni et al. · European Journal of Medicinal Chemistry · 2017 · 42 citations · Full text

, , +16

1–5 of 9